Inflammatory signaling in cartilage:: MAPK and NF-κB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis

被引:141
作者
Saklatvala, Jeremy [1 ]
机构
[1] Imperial Coll London, Kennedy Inst Rheumatol, London W6 8LH, England
基金
英国医学研究理事会;
关键词
chondrocyte; MAP kinase; NF-kappa B; matrix metalloproteinase; protein kinase; protein kinase inhibitor; inflammatory response; osteoarthritis;
D O I
10.2174/138945007779940115
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Osteoarthritis is characterised by degeneration of articular cartilage. It is thought to be primarily a disease of cartilage. Inflammatory response genes, such as proteinases, cyclooxygenase, and cytokines are implicated in its pathogenesis. The evidence for expression of these genes in articular cartilage in osteoarthritis is reviewed. The expression of inflammatory response genes is controlled by four major intracellular signalling pathways. These lead to activation of the three mitogen-activated protein kinases (MAPK) and the transcriptional regulator nuclear factor kappa (NF kappa)-B. The current state of knowledge of the structure of these pathways is summarized. Pharmacological inhibitors of the protein kinases of the pathways in current use are described, and insights into chondrocyte gene expression obtained with them are discussed. Very limited use of these inhibitors has yet been made in animal models of osteoarthritis.
引用
收藏
页码:305 / 313
页数:9
相关论文
共 106 条
[1]  
Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO
[2]  
2-H
[3]   INDEPENDENT EXPRESSION OF FIBRIL-FORMING COLLAGEN-I, COLLAGEN-II, AND COLLAGEN-III IN CHONDROCYTES OF HUMAN OSTEOARTHRITIC CARTILAGE [J].
AIGNER, T ;
BERTLING, W ;
STOSS, H ;
WESELOH, G ;
VONDERMARK, K .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :829-837
[4]   PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[5]   Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage - Influence of nitric oxide [J].
Amin, AR ;
Attur, M ;
Patel, RN ;
Thakker, GD ;
Marshall, PJ ;
Rediske, J ;
Stuchin, SA ;
Patel, IR ;
Abramson, SB .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1231-1237
[6]   THE EXPRESSION AND REGULATION OF NITRIC-OXIDE SYNTHASE IN HUMAN OSTEOARTHRITIS-AFFECTED CHONDROCYTES - EVIDENCE FOR UP-REGULATED NEURONAL NITRIC-OXIDE SYNTHASE [J].
AMIN, AR ;
DICESARE, PE ;
VYAS, P ;
ATTUR, M ;
TZENG, E ;
BILLAR, TR ;
STUCHIN, SA ;
ABRAMSON, SB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :2097-2102
[7]  
Amin Ashok R., 1998, Current Opinion in Rheumatology, V10, P263, DOI 10.1097/00002281-199805000-00018
[8]   Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine [J].
Attur, MG ;
Dave, M ;
Akamatsu, M ;
Katoh, M ;
Amin, AR .
OSTEOARTHRITIS AND CARTILAGE, 2002, 10 (01) :1-4
[9]   Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures [J].
Badger, AM ;
Roshak, AK ;
Cook, MN ;
Newman-Tarr, TM ;
Swift, BA ;
Carlson, K ;
Connor, JR ;
Lee, JC ;
Gowen, M ;
Lark, MW ;
Kumar, S .
OSTEOARTHRITIS AND CARTILAGE, 2000, 8 (06) :434-443
[10]   The specificities of protein kinase inhibitors: an update [J].
Bain, J ;
McLauchlan, H ;
Elliott, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2003, 371 :199-204